Investing Profile

Samuel Bjork

VCInvestor
Partner at Digitalis Ventures
Photo of Samuel Bjork, Partner at Digitalis Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
10
$300M
CompanyStageDateRound SizeTotal Raised
EpiBiologics
Series BJan 2026$110M
Series AJul 2023$23M
$200M
Co-investors: David Schenkein (GV (Google Ventures)), Alexandra Cantley (Polaris Partners), Nisa Leung (Qiming Venture Partners), Alaa Halawa (Mubadala), Gaurav Aggarwal (Vivo Capital)
T-Therapeutics
Series ANov 2025$32M
Series ANov 2023$60M
$92M
Co-investors: Nihal Sinha (F-Prime Capital Partners), Robert Tansley (Cambridge Innovation Capital), Graziano Seghezzi (Soffinova Partners)
Judo Bio
Series AOct 2024$75M
$100M
Co-investors: Kevin Bitterman (Atlas Venture), Jeff Goater (The Column Group), Steven Robinette (Atlas Venture)
Bonum Therapeutics
Series ANov 2022$93M
$93M
Co-investors: Karl Handelsman (Codon Capital), John McKearn (RiverVest), Monique Schiersing (Roche Venture Fund)
Good Therapeutics
Series BDec 2021$8M
Series AMay 2020$11M
Series AJan 2019$11M
$30M
Co-investors: John McKearn (RiverVest), Monique Schiersing (Roche Venture Fund)
MollyBox
Series BNov 2019$13M
$13M